BioSpace News Archive

BioMidwest

Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms With Latera From Spirox

The 18 and 24-month data reinforces clinical benefits without cosmetic downside.

October 30, 2017

·

3 min read

FDA Approves BriaCell’s Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to BriaVax in Patients With Advanced Breast Cancer

The study allows the patients who did not respond to BriaVax to be treated in combination with either pembrolizumab or ipilimumab.

October 30, 2017

·

6 min read

Pharm Country

Cancer Genetics -- a Leader in Personalized Medicine -- Launches AntigenID, Solidifying CGI’s Position as a Precision Oncology Leader in the Fast Growing, Rapidly-Evolving Field of Immuno-Oncology Therapy & Drug Development

AntigenID is a new service based on neoantigen identification technology utilizing unique and comprehensive sequencing combinations and sophisticated bioinformatics algorithms and computational workflows.

October 30, 2017

·

7 min read

Drug Development

Five Prime Therapeutics Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity With FPT155

October 30, 2017

·

4 min read

Biotech Bay

Episona Presents Data on Sperm DNA Methylation Patterns at ASRM Congress Expo

Episona announced data of a prospective, controlled, multi-institutional clinical trial of 210 patients which appears to illustrate emerging and robust relationships between sperm DMPs and abnormal semen parameters among infertile couples.

October 30, 2017

·

2 min read

Business

CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics

The novel production facility - called GMP IV - will be able to produce approximately 30 million doses of RNA-based therapeutics per year, and is expected to be fully commissioned in 2019.

October 30, 2017

·

2 min read

Drug Development

Biothera Pharmaceuticals Presents Preclinical Data Showing Imprime PGG Activates Natural Killer Cell-Mediated Tumor Killing

The data will be presented at the AACR-NCI-EORTC International Conference.

October 30, 2017

·

2 min read

Business

Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017

Management will host a webcast and conference call that day at 8:30 a.m. ET to discuss these results and updates.

October 30, 2017

·

1 min read

Alpha Tau Medical Initiates First Clinical Trial in Italy to Treat Cancer With Alpha Radiation

The team hopes that the results from the study at IRST will further reinforce the promising preliminary results of the ongoing SCC study at the Rabin Medical Center, Israel.

October 30, 2017

·

1 min read

Drug Development

Vaxart Announces Positive Safety and Immunogenicity Results for Its Oral Norovirus Vaccine in A Phase 1b Clinical Study

The norovirus tablet vaccine was generally well tolerated in all subjects. Adverse events (AEs) were mostly mild in severity with headache as the most frequent AE.

October 30, 2017

·

7 min read